PDS Biotechnology PDSB
NASDAQ PDSB
$0.75 +0.04 (+5.63%)
At close: Oct 2, 2026 · 4:00 PM EDT

PDS Biotechnology (PDSB) Cash from Investing Activities (2014 - 2024)

Updated

PDS Biotechnology's Cash from Investing Activities came in at -$29,000 for FY2024.

Analysis

PDS Biotechnology (PDSB) Cash from Investing Activities (2014 - 2024) Analysis & Trends

Going back to FY2013, PDS Biotechnology's Cash from Investing Activities data covers 7 years.

  • The FY2024 figure represents the highest annual Cash from Investing Activities since FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 PDS Biotechnology 41.94 Mn 41.94 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -1.00
Dec 31, 2019 275,001.00
Mar 31, 2019 29.11 Mn
Dec 31, 2017 -27,970.00
Sep 30, 2017 -55,089.00
Jun 30, 2017 -16,378.00
Mar 31, 2017 -89,284.00
Dec 31, 2016 -347,295.00
Sep 30, 2016 -144,093.00
Jun 30, 2016 -118,030.00
Mar 31, 2016 -77,287.00
Dec 31, 2015 -505,662.00
Sep 30, 2015 -352,254.00
Jun 30, 2015 -361,092.00
Mar 31, 2015 -86,078.00
Dec 31, 2014 -619,643.00
API Access

PDS Biotechnology Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=PDSB&period=max&api_key=YOUR_API_KEY